GPX4 and cancer: Some small molecules (e.g., erastin and RSL3) and clinical cancer drugs (e.g., sorafenib, sulfasalazine, and artesunate) induced cell death via the inhibition of system Xc− and GPx4 in various types of cancer cells [6,7,19].